Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market Size and Forecast, By Product Type
4.2. Lancing Devices and Strips
4.3. Blood-Glucose Meter
Chapter 5: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Type-1 Diabetes
5.3. Type-2 Diabetes
Chapter 6: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER
6.1. Overview
6.1.1. Market Size and Forecast, By End User
6.2. Hospitals and Clinics
6.3. Home Care Settings
6.4. Others
Chapter 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022
Chapter 8: COMPANY PROFILES
8.1. Roche
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Abbott
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.2.7. Key strategic moves and developments
8.3. Medtronic
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.3.7. Key strategic moves and developments
8.4. Siemens Healthineers
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Bayer
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. Novo Nordisk
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Pentax Medical
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.7.7. Key strategic moves and developments
8.8. OptiMedis
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.8.7. Key strategic moves and developments
8.9. ZEISS Group
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Business performance
8.9.7. Key strategic moves and developments
8.10. B. Braun Melsungen AG
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
8.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 10. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY PRODUCT TYPE, 2022 ($MILLION)
FIGURE 11. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET,BY END USER, 2022 ($MILLION)
FIGURE 13. TOP WINNING STRATEGIES, BY YEAR
FIGURE 14. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 15. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 16. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 17. COMPETITIVE DASHBOARD
FIGURE 18. COMPETITIVE HEATMAP: GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET
FIGURE 19. TOP PLAYER POSITIONING, 2022
FIGURE 20. ROCHE: NET SALES, 2020-2022*?($MILLION)
FIGURE 21. ROCHE: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 22. ROCHE: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 23. ABBOTT: NET SALES, 2020-2022*?($MILLION)
FIGURE 24. ABBOTT: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 25. ABBOTT: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 26. MEDTRONIC: NET SALES, 2020-2022*?($MILLION)
FIGURE 27. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 28. MEDTRONIC: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 29. SIEMENS HEALTHINEERS: NET SALES, 2020-2022*?($MILLION)
FIGURE 30. SIEMENS HEALTHINEERS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 31. SIEMENS HEALTHINEERS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 32. BAYER: NET SALES, 2020-2022*?($MILLION)
FIGURE 33. BAYER: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 34. BAYER: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 35. NOVO NORDISK: NET SALES, 2020-2022*?($MILLION)
FIGURE 36. NOVO NORDISK: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 37. NOVO NORDISK: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 38. PENTAX MEDICAL: NET SALES, 2020-2022*?($MILLION)
FIGURE 39. PENTAX MEDICAL: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 40. PENTAX MEDICAL: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 41. OPTIMEDIS: NET SALES, 2020-2022*?($MILLION)
FIGURE 42. OPTIMEDIS: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 43. OPTIMEDIS: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 44. ZEISS GROUP: NET SALES, 2020-2022*?($MILLION)
FIGURE 45. ZEISS GROUP: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 46. ZEISS GROUP: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 47. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022*?($MILLION)
FIGURE 48. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 49. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 04. ROCHE: KEY EXECUTIVES
TABLE 05. ROCHE: COMPANY SNAPSHOT
TABLE 06. ROCHE: OPERATING SEGMENTS
TABLE 07. ROCHE: PRODUCT PORTFOLIO
TABLE 08. ROCHE: KEY STRATERGIES
TABLE 09. ABBOTT: KEY EXECUTIVES
TABLE 10. ABBOTT: COMPANY SNAPSHOT
TABLE 11. ABBOTT: OPERATING SEGMENTS
TABLE 12. ABBOTT: PRODUCT PORTFOLIO
TABLE 13. ABBOTT: KEY STRATERGIES
TABLE 14. MEDTRONIC: KEY EXECUTIVES
TABLE 15. MEDTRONIC: COMPANY SNAPSHOT
TABLE 16. MEDTRONIC: OPERATING SEGMENTS
TABLE 17. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 18. MEDTRONIC: KEY STRATERGIES
TABLE 19. SIEMENS HEALTHINEERS: KEY EXECUTIVES
TABLE 20. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 21. SIEMENS HEALTHINEERS: OPERATING SEGMENTS
TABLE 22. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
TABLE 23. SIEMENS HEALTHINEERS: KEY STRATERGIES
TABLE 24. BAYER: KEY EXECUTIVES
TABLE 25. BAYER: COMPANY SNAPSHOT
TABLE 26. BAYER: OPERATING SEGMENTS
TABLE 27. BAYER: PRODUCT PORTFOLIO
TABLE 28. BAYER: KEY STRATERGIES
TABLE 29. NOVO NORDISK: KEY EXECUTIVES
TABLE 30. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 31. NOVO NORDISK: OPERATING SEGMENTS
TABLE 32. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 33. NOVO NORDISK: KEY STRATERGIES
TABLE 34. PENTAX MEDICAL: KEY EXECUTIVES
TABLE 35. PENTAX MEDICAL: COMPANY SNAPSHOT
TABLE 36. PENTAX MEDICAL: OPERATING SEGMENTS
TABLE 37. PENTAX MEDICAL: PRODUCT PORTFOLIO
TABLE 38. PENTAX MEDICAL: KEY STRATERGIES
TABLE 39. OPTIMEDIS: KEY EXECUTIVES
TABLE 40. OPTIMEDIS: COMPANY SNAPSHOT
TABLE 41. OPTIMEDIS: OPERATING SEGMENTS
TABLE 42. OPTIMEDIS: PRODUCT PORTFOLIO
TABLE 43. OPTIMEDIS: KEY STRATERGIES
TABLE 44. ZEISS GROUP: KEY EXECUTIVES
TABLE 45. ZEISS GROUP: COMPANY SNAPSHOT
TABLE 46. ZEISS GROUP: OPERATING SEGMENTS
TABLE 47. ZEISS GROUP: PRODUCT PORTFOLIO
TABLE 48. ZEISS GROUP: KEY STRATERGIES
TABLE 49. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 50. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 51. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 52. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 53. B. BRAUN MELSUNGEN AG: KEY STRATERGIES